Basic and Clinical Research on the Therapeutic Effect of Intervention in Primary Liver Cancer by Targeted Intra-Arterial Verapamil Infusion

Cell Biochemistry and Biophysics

Volumn 62, Issue 1, 2012, Pages 59-67

  Pingsheng, Fan ^a   Tengyue, Zhang ^a   Qiang, Huang ^b   Qiang, Wei ^a   Xin, Sun ^c   Liting, Qian ^a  

^a Anhui Tumor Hospital   (China)

^b ANHUI PROVINCIAL HOSPITAL   (China)

^c ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Interventional therapy; Intra arterial infusion; Multi drug resistance; Primary liver cancer; Verapamil

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ANTINEOPLASTIC AGENT; ASPARTATE AMINOTRANSFERASE; VASODILATOR AGENT; VERAPAMIL;

ADULT; AGED; ANIMAL; ARTICLE; BLOOD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MODEL; DOG; DRUG COMBINATION; DRUG EFFECT; DRUG RESISTANCE; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; ALANINE TRANSAMINASE; ALPHA-FETOPROTEINS; ANIMALS; ANTINEOPLASTIC AGENTS; ASPARTATE AMINOTRANSFERASES; DISEASE MODELS, ANIMAL; DOGS; DRUG RESISTANCE, NEOPLASM; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LIVER NEOPLASMS; MALE; MIDDLE AGED; VASODILATOR AGENTS; VERAPAMIL;

CANIS FAMILIARIS;

EID: 84855572895     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12013-011-9259-4     Document Type: Article

References (24)

1. Llovet, J. M., Bruix, J., & Gores, G. J. (2000). Surgical resection versus transplantation for early hepatocellular carcinoma: Clues for the best strategy. Hepatology, 31, 1019-1021.
2. Veltri, A., Moretto, P., Doriguzzi, A., et al. (2006). Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combinedtherapy for unresectable non-early hepatocellular carcinoma (HCC). European Radiology, 16(3), 661-669.
3. Sun, Z., Zhao, Z., Li, G., et al. (2010). Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: In vivo and clinical studies. Tumori, 96(1), 90-96.
4. Miller, T. P., Grogan, T. M., et al. (1991). P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil. Journal of Clinical Oncology, 9, 17-24.
5. Salmon, S. E., Dalton, W. S., Grogan, T. M., et al. (1991). Multidrug-resistant myeloma: Laboratory and clinical effects of verapamil as a chemosensitizer. Blood, 78(1), 44-50.
6. Ford, J. M., & Hait, W. N. (1990). Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacological Reviews, 42, 155-199.
7. Baumert, C., & Hilgeroth, A. (2009). Recent advances in the development of P-gp inhibitors. Anticancer Agents Medicinal Chemistry, 9(4), 415-436.
8. Huang, J., Duan, Q., & Fan, P. (2011). Clinical evaluation of targeted arterial infusion of verapamil in the interventional chemotherapy of primary hepatocellular carcinoma. Cell Biochemistry and Biophysics, 59(2), 127-132.
9. Trotti, A., Byhardt, R., Stetz, J., Gwede, C., Corn, B., Fu, K., et al. (2000). Common toxicity criteria: Version 2. 0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. International Journal Radiation Oncology Biology Physics, 47(1), 13-47.
10. The Criteria Committee of the New York Heart Association. (1994). Nomenclature and criteria for diagnosis of diseases of the heart and great vessels (9th ed., pp. 253-256). Boston: Little, Brown & Co.
11. Pugh, R. N. H., Murray-Lyon, I. M., Dawson, J. L., et al. (1973). Transection of the esophagus for bleeding esophageal varises. British Journal of Surgery, 60, 646.
12. Chen, G., Ma, D. Q., He, W., Zhang, B. F., & Zhao, L. Q. (2008). Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma. World Journal of Gastroenterology, 14(37), 5738-5743.
13. Liu, Y. M., Qin, H., Wang, C. B., et al. (2007). Comparison of different interventional therapies for primary liver cancer. Zhonghua Zhong Liu Za Zhi, 29(3), 232-235.
14. Shi, H., Lu, D., Shu, Y., Shi, W., et al. (2008). Expression of multidrug resistance-related proteins p-glycoprotein glutathione-s-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma. Cancer Investigation, 26(4), 344-351.
15. Ludwig, J. A., Szakács, G., Martin, S. E., et al. (2006). Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer. Cancer Research, 66(9), 4808-4815.
16. Alahari, S. K., DeLong, R., Fisher, M. H., Dean, N. M., Viliet, P., & Juliano, R. L. (1998). Novel chemically modified oligonucleotides provide potent inhibition of P-glycoprotein expression. Journal of Pharmacology and Experimental Therapeutics, 286(1), 419-428.
17. Wang, B. L., Chen, X. P., & Zhai, S. P. (2003). Expression and implication of multidrug resistance associated-protein gene in primary hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi, 11(10), 609-611.
18. Wang, B. L., Chen, X. P., Zhai, S. P., et al. (2003). Clinical significance of mrp gene in primary hepatocellular carcinoma. Hepatobiliary Pancreatic Disease International, 2(3), 397-403.
19. Ford, J. M., & Hait, W. N. (1990). Pharmacology of drugs that alter multidrug resistance. Cancer Pharmacology Review, 42(3), 155-199.
20. Shudo, N., Mizoguchi, T., Kiyosue, T., et al. (1990). Two pyridine analogues with more effective ability to reverse multidrug resistance and with lower calcium channel blocking activity than their dihydropyridine counterparts. Cancer Research, 50(10), 3055-3061.
21. Muller, C., Bailly, J. D., Goubin, F., et al. (1994). Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines. International Journal of Cancer, 56(5), 749-754.
22. Buijs, M., Vossen, J. A., Frangakis, C., Hong, K., Georgiades, C. S., Chen, Y., et al. (2008). Nonresectable hepatocellular carcinoma: Long-term toxicity in patients treated with transarterial chemoembolization-single-center experience. Radiology, 249(1), 346-354.
23. Kirchhoff, T. D., Bleck, J. S., Dettmer, A., Chavan, A., Rosenthal, H., Merkesdal, S., et al. (2007). Transarterial chemoembolization using degradable starch microspheres and iodized oil in the treatment of advanced hepatocellular carcinoma: evaluation of tumor response, toxicity, and survival. Hepatobiliary Pancreatic Diseases International, 6(3), 259-266.
24. Liu, Y. M., Qin, H., Wang, C. B., Fang, X. H., & Ma, Q. Y. (2006). Comparison of therapeutic effectiveness of combined interventional therapy for 1126 cases of primary liver cancer. World Journal of Gastroenterology, 12(31), 5060-5063.